Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Vadim Sherman"'
Autor:
Shaoshuai Xie, Leila Saba, Hua Jiang, Omar R Bringas, Mehrnoosh Oghbaie, Luciano Di Stefano, Vadim Sherman, John LaCava
Publikováno v:
BioTechniques, Vol 76, Iss 4, Pp 145-152 (2024)
Immunoprecipitation (IP) coupled with mass spectrometry effectively maps protein–protein interactions when genome-wide, affinity-tagged cell collections are used. Such studies have recorded significant portions of the compositions of physiological
Externí odkaz:
https://doaj.org/article/cd3df74433d04441b4920c65549a30d8
Autor:
Nesrin M. Hasan, Kelli F. Johnson, Jianyi Yin, Nicholas W. Baetz, Lea Fayad, Vadim Sherman, Sarah E. Blutt, Mary K. Estes, Vivek Kumbhari, Nicholas C. Zachos, Olga Kovbasnjuk
Publikováno v:
Molecular Metabolism, Vol 44, Iss , Pp 101129- (2021)
Objective: The mechanisms behind the efficacy of bariatric surgery (BS) for treating obesity and type 2 diabetes, particularly with respect to the influence of the small bowel, remain poorly understood. In vitro and animal models are suboptimal with
Externí odkaz:
https://doaj.org/article/25e0bcf24af540379f8523f80e6a8a1a
Autor:
Ugoeze Nwokedi, Mahnoor Zia, Jiaqiong Xu, Archana R. Sadhu, Flavio E. Baio, Bita S. Kash, Vadim Sherman, Nabil Tariq
Publikováno v:
Surgical Endoscopy. 36:6915-6923
In cardiac and orthopedic surgery, elevated glycosylated hemoglobin (HbA1c) is a modifiable risk factor for postoperative complications. However, in bariatric surgery, there is insufficient evidence to assess the effectiveness of preoperative HbA1c a
Autor:
Nabil Tariq, Ashish Saharia, Ugoeze Nwokedi, Mark J. Hobeika, Constance M. Mobley, David Hsu, Lucy M. Potter, Linda W. Moore, Ahmed Elaileh, Vadim Sherman, R. Mark Ghobrial
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyREFERENCES.
Pretransplantation bariatric surgery in patients with high Model for End-Stage Liver Disease (MELD) score is fraught with risks. Bariatric surgery after liver transplantation (LT) may be complicated by surgical adhesions but could have advantages if
Autor:
Arvind Bhimaraj, Juha Baek, Fernando Ramirez Del Val, Jerry D. Estep, Nabil Tariq, Terri Menser, Bita A. Kash, Vadim Sherman, Stephen L. Jones, Ohbet Cheon
Publikováno v:
Journal of Cardiac Failure. 26:944-947
Orthotopic heart transplantation (OHT) is contraindicated in morbidly obese patients with end-stage heart failure (HF), for whom cardiac allograft is the only means for long-term survival. Bariatric surgery may allow them to achieve target body mass
Autor:
Mahnoor Zia, Jiaqiong Xu, Stevenson Tsiao, Archana Sadhu, Flavio Baio, Vadim Sherman, Nabil Tariq
Publikováno v:
Journal of the American College of Surgeons. 235:S1-S1
Autor:
Basem Soliman, Vadim Sherman, Bita A. Kash, Linda W. Moore, Yi Ying Law, Rita Bosetti, A. Osama Gaber, Stephanie G. Yi, Nwabunie Nwana, Nabil Tariq
Publikováno v:
Obesity Surgery.
Severe obesity can increase risk of complications after kidney transplantation. There is a paucity of literature on bariatric surgery outcomes in renal transplant candidates. The objective of this study was to analyze outcomes of bariatric surgery as
Autor:
Vivek Kumbhari, Mary K. Estes, Nicholas W. Baetz, Nesrin Hasan, Kelli F. Johnson, Nicholas C. Zachos, Jianyi Yin, Lea Fayad, Olga Kovbasnjuk, Vadim Sherman, Sarah E. Blutt
Publikováno v:
Molecular Metabolism
Molecular Metabolism, Vol 44, Iss, Pp 101129-(2021)
Molecular Metabolism, Vol 44, Iss, Pp 101129-(2021)
Objective The mechanisms behind the efficacy of bariatric surgery (BS) for treating obesity and type 2 diabetes, particularly with respect to the influence of the small bowel, remain poorly understood. In vitro and animal models are suboptimal with r
Autor:
Jianyi Yin, Nesrin M. Hasan, Vadim Sherman, Nicholas C. Zachos, Mary K. Estes, Sarah E. Blutt, Vivek Kumbhari, Olga Kovbasnjuk, Nicholas W. Baetz, Kelli F. Johnson
Obesity and obesity-related comorbidities are significant health care challenges. Bariatric surgery (BS) is the most effective therapy for treating obesity and type 2 diabetes. A barrier in the development of therapeutic alternatives is incomplete me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbb90b116972874061f574036bbb64d5
https://doi.org/10.1101/2020.05.29.123737
https://doi.org/10.1101/2020.05.29.123737
Autor:
Nwabunie Nwana, Vadim Sherman, Nabil Tariq, Basem Soliman, Rita Bosetti, A O Gaber, Dan Mija, Linda W. Moore, Bita A. Kash
Publikováno v:
Surgery for Obesity and Related Diseases. 15:S56-S58